Insider Trading Alert - CAVM, IPGP And MOH Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 27, 2014, 119 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.26 to $40,800,000.00.

Highlighted Stocks Traded by Insiders:

Cavium (CAVM) - FREE Research Report

Chadwick Arthur D who is VP Finance & Admin CFO at Cavium sold 18,250 shares at $42.00 on Feb. 27, 2014. Following this transaction, the VP Finance & Admin CFO owned 29,600 shares meaning that the stake was reduced by 38.14% with the 18,250-share transaction.

Jain Anil Kumar who is Corporate VP, IC Engineering at Cavium sold 3,750 shares at $42.50 on Feb. 27, 2014. Following this transaction, the Corporate VP, IC Engineering owned 55,750 shares meaning that the stake was reduced by 6.3% with the 3,750-share transaction.

The shares most recently traded at $43.21, up $0.71, or 1.64% since the insider transaction. Historical insider transactions for Cavium go as follows:

  • 4-Week # shares sold: 201,500
  • 12-Week # shares sold: 201,500
  • 24-Week # shares sold: 201,500

The average volume for Cavium has been 683,500 shares per day over the past 30 days. Cavium has a market cap of $2.2 billion and is part of the technology sector and electronics industry. Shares are up 22.8% year-to-date as of the close of trading on Thursday.

Cavium, Inc. designs, develops, and markets semiconductor processors for intelligent and secure networks. Currently there are 10 analysts that rate Cavium a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAVM - FREE

TheStreet Quant Ratings rates Cavium as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Cavium Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

IPG Photonics Corporation (IPGP) - FREE Research Report

Valentin Gapontsev Trust I who is 10% Owner at IPG Photonics Corporation sold 20,000 shares at $67.34 on Feb. 27, 2014. Following this transaction, the 10% Owner owned 7.9 million shares meaning that the stake was reduced by 0.25% with the 20,000-share transaction.

The shares most recently traded at $71.27, up $3.93, or 5.51% since the insider transaction. Historical insider transactions for IPG Photonics Corporation go as follows:

  • 4-Week # shares sold: 49,333
  • 12-Week # shares sold: 64,333
  • 24-Week # shares sold: 74,833

The average volume for IPG Photonics Corporation has been 413,100 shares per day over the past 30 days. IPG Photonics Corporation has a market cap of $3.5 billion and is part of the technology sector and electronics industry. Shares are down 12.15% year-to-date as of the close of trading on Thursday.

IPG Photonics Corporation develops and manufactures fiber lasers, fiber amplifiers, and diode lasers that are used in various applications, primarily in materials processing. The company has a P/E ratio of 23.0. Currently there are 7 analysts that rate IPG Photonics Corporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IPGP - FREE

TheStreet Quant Ratings rates IPG Photonics Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full IPG Photonics Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Molina Healthcare (MOH) - FREE Research Report

Barlow Jeff D. who is Chief Legal Officer at Molina Healthcare sold 10,232 shares at $37.58 on Feb. 27, 2014. Following this transaction, the Chief Legal Officer owned 54,801 shares meaning that the stake was reduced by 15.73% with the 10,232-share transaction.

The shares most recently traded at $38.08, up $0.50, or 1.3% since the insider transaction. Historical insider transactions for Molina Healthcare go as follows:

  • 4-Week # shares sold: 24,144
  • 12-Week # shares sold: 26,518
  • 24-Week # shares sold: 26,518

The average volume for Molina Healthcare has been 600,800 shares per day over the past 30 days. Molina Healthcare has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 7.6% year-to-date as of the close of trading on Thursday.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as to assist state agencies in their administration of the Medicaid program. The company has a P/E ratio of 39.0. Currently there are 3 analysts that rate Molina Healthcare a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOH - FREE

TheStreet Quant Ratings rates Molina Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Molina Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?